Cat.
No. Description
Curr.
Lot.
Purity
Value/Conc.
Change
Code*
Previous
Lot/Valid
Use Date
CAS
No. Price
1283426 Fosinopril Related Compound B ( 15 mg) ((4S)-
4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpro-
poxy](4-phenylbutyl)phosphinyl]acetyl-D-proline
propionate (ester), hemibarium salt, sesquihy-drate)
F0F337 n/f $636
1283437 Fosinopril Related Compound C ( 15 mg) ((4S)-
4-cyclohexyl-1-[(RS)-1-hydroxy-2-methylpro-
poxy](4-phenylbutyl)phosphinyl]-acetyl-L-proline
propionate (ester), sodium salt)
F0F339 n/f $636
1283448 Fosinopril Related Compound D ( 15 mg) ((4R)-
4-cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpro-
poxy](4-phenylbutyl)phosphinyl]acetyl-L-proline
propionate (ester), sodium salt)
F0F340 n/f $636
1283459 Fosinopril Related Compound E ( 15 mg) ((4S)-
4-phenyl-1-[(R)-[(S)-1-hydroxy-2-methyl-pro-
poxy](4-phenylbutyl)phospinyl]acetyl-L-proline
propionate (ester), sodium salt)
F0F341 n/f $636
1283460 Fosinopril Related Compound F ( 15 mg) ((4S)-
4-cyclohexyl-1-[(R)-[(S)-1-hydroxypropoxy](4-
phenylbutyl)phosphinyl]acetyl-L-proline propio-nate(ester), sodium salt)
F0F344 n/f $636
1283470 Fosinopril Related Compound G ( 15 mg) ((4-
phenylbutyl)phosphinyl acetic acid, disodium
salt)
F0F345 n/f $636
1283481 Fosinopril Related Compound H ( 25 mg) (4-
phenylbutyl phosphonic acid)
F0F346 [46348-61-2] $636
1286366 Fosphenytoin Sodium ( 250 mg) G0E124 0.999 mg/mg (an) F0C156 (07/06) [92134-98-0] $204
1286504 Fructose ( 125 mg) J0J006 0.999 mg/mg (ai) I3E340 (10/11)
I-2 (04/07)
I-1 (11/02)
I (08/99)
[57-48-7] $162
1286606 L-Fucose ( 200 mg) (AS) F0E007 [2438-80-4] $214
1286650 Fulvestrant ( 150 mg) F0H065 0.993 mg/mg (ai) [129453-61-8] $507
1286661 Fulvestrant System Suitability Mixture ( 15 mg) F0H069 see composition
$647
1286708 Fumaric Acid ( 200 mg) H0E328 1.00 mg/mg (ai) G- 1 (03/07)
G (04/02)
[110-17-8] $204
1286800 Furazolidone ( 200 mg) H0I140 0.999 mg/mg (ai) G- 2 (09/10)
G- 1 (01/01)
[67-45-8] $204
1287008 Furosemide ( 200 mg) L0H311 0.995 mg/mg (ai) K0F188 (06/10)
J1B131 (10/07)
J (10/03)
[54-31-9] $204
1287020 Furosemide Related Compound A ( 50 mg) (2-
Chloro-4-N-furfurylamino-5-sulfamoylbenzoic
Acid)
K0I004 0.99 mg/mg (ai) J1F187 (12/10)
J (08/07)
I (08/02)
n/f $636
1287030 Furosemide Related Compound B ( 100 mg) (4-
Chloro-5-sulfamoylanthranilic Acid)
K0H287 0.99 mg/mg (ai) J0E326 (03/10)
H (08/04)
G- 3 (03/01)
[3086-91-7] $636
1287303 Gabapentin ( 250 mg) I0K190 0.998 mg/mg (ai) 2 H0J020 (09/12)
G0E005 (08/11)
F (03/06)
[60142-96-3] $204
1287325 Gabapentin Related Compound A ( 50 mg) ( 3,3-
pentamethylene-5-butyrolactam)
H0I134 1.00mg/mg (ai) G0E125 (11/10)
F1D263 (07/06)
F (10/05)
[64744-50-9] $636
1287347 Gabapentin Related Compound B ( 30 mg) ((1-
cyanocyclohexyl)acetic acid)
F0F232 [133481-09-1] $636
January–February 2012 Official USP Reference Standards Catalog 61
*See “How to Read” section for Change Code Interpretation.
www.usp.org Note: Where the Current Lot is blank, the item is not in distribution.
USP Reference Standards and Authentic Substances
